Journal of Peking University (Health Sciences) ›› 2023, Vol. 55 ›› Issue (2): 276-282. doi: 10.19723/j.issn.1671-167X.2023.02.011
Previous Articles Next Articles
CLC Number:
1 | Eble JN, Sauter G, Epstein JI, et al. World Health Organization classification of tumours: Pathology and genetics of tumours of the urinary system and male genital organs[R]. Lyon, France: International Agency for Research on Cancer, 2004. |
2 | Moch H, Humphrey P, Ulbright T, et al. World Health Organization classification of tumours of the urinary system and male genital organs[R]. Lyon, France: International Agency for Research on Cancer, 2016. |
3 |
MacLennan GT , Farrow GM , Bostwick DG . Low-grade collecting duct carcinoma of the kidney: Report of 13 cases of low-grade mucinous tubulocystic renal carcinoma of possible collecting duct origin[J]. Urology, 1997, 50 (5): 679- 684.
doi: 10.1016/S0090-4295(97)00335-X |
4 |
Ged Y , Chen YB , Knezevic A , et al. Mucinous tubular and spindle-cell carcinoma of the kidney: Clinical features, genomic profiles, and treatment outcomes[J]. Clin Genitourin Cancer, 2019, 17 (4): 268- 274.
doi: 10.1016/j.clgc.2019.04.006 |
5 |
Xu X , Zhong J , Zhou X , et al. Mucinous tubular and spindle cell carcinoma of the kidney: A study of clinical, imaging features and treatment outcomes[J]. Front Oncol, 2022, 12, 865263.
doi: 10.3389/fonc.2022.865263 |
6 |
Ferlicot S , Allory Y , Comperat E , et al. Mucinous tubular and spindle cell carcinoma: A report of 15 cases and a review of the literature[J]. Virchows Arch, 2005, 447 (6): 978- 983.
doi: 10.1007/s00428-005-0036-x |
7 |
Rakozy C , Schmahl GE , Bogner S , et al. Low-grade tubular-mucinous renal neoplasms: Morphologic, immunohistochemical, and genetic features[J]. Mod Pathol, 2002, 15 (11): 1162- 1171.
doi: 10.1097/01.MP.0000031709.40712.46 |
8 |
Nathany S , Monappa V . Mucinous tubular and spindle cell carcinoma: A review of histopathology and clinical and prognostic implications[J]. Arch Pathol Lab Med, 2020, 144 (1): 115- 118.
doi: 10.5858/arpa.2017-0506-RS |
9 | Xiao L , Xiao W , Guo Y , et al. Huge mucinous tubular and spindle cell carcinoma of the kidney: A case report[J]. Urol Case Rep, 2021, 40, 101914. |
10 |
Bajpai M , Pooja S , Tyagi M , et al. Mucinous spindle and tubular renal cell cancer: A rare variant of renal cell cancer[J]. J Cancer Res Ther, 2022, 18 (4): 1168- 1170.
doi: 10.4103/jcrt.jcrt_99_21 |
11 | Kuroda N , Hes O , Michal M , et al. Mucinous tubular and spindle cell carcinoma with Fuhrman nuclear grade 3: A histological, immunohistochemical, ultrastructural and FISH study[J]. Histol Histopathol, 2008, 23 (12): 1517- 1523. |
12 |
Fuchizawa H , Kijima T , Takada-Owada A , et al. Metastatic mucinous tubular and spindle cell carcinoma of the kidney responding to nivolumab plus ipilimumab[J]. IJU Case Rep, 2021, 4 (5): 333- 337.
doi: 10.1002/iju5.12342 |
13 |
Arafah M , Zaidi SN . Mucinous tubular and spindle cell carcinoma of the kidney with sarcomatoid transformation[J]. Saudi J Kidney Dis Transplant, 2013, 24 (3): 557- 560.
doi: 10.4103/1319-2442.111066 |
14 |
Bulimbasic S , Ljubanovic D , Sima R , et al. Aggressive high-grade mucinous tubular and spindle cell carcinoma[J]. Hum Pathol, 2009, 40 (6): 906- 907.
doi: 10.1016/j.humpath.2009.03.004 |
15 |
Pillay N , Ramdial PK , Cooper K , et al. Mucinous tubular and spindle cell carcinoma with aggressive histomorphology: A sarco-matoid variant[J]. Hum Pathol, 2008, 39 (6): 966- 969.
doi: 10.1016/j.humpath.2007.10.006 |
16 | Simon RA , di Sant'agnese PA , Palapattu GS , et al. Mucinous tubular and spindle cell carcinoma of the kidney with sarcomatoid differentiation[J]. Int J Clin Exp Pathol, 2008, 1 (2): 180- 184. |
17 |
Dhillon J , Amin MB , Selbs E , et al. Mucinous tubular and spindle cell carcinoma of the kidney with sarcomatoid change[J]. Am J Surg Pathol, 2009, 33 (1): 44- 49.
doi: 10.1097/PAS.0b013e3181829ed5 |
18 |
Fine SW , Argani P , DeMarzo AM , et al. Expanding the histologic spectrum of mucinous tubular and spindle cell carcinoma of the kidney[J]. Am J Surg Pathol, 2006, 30, 1554- 1560.
doi: 10.1097/01.pas.0000213271.15221.e3 |
19 |
Reuter VE , Argani P , Zhou M , et al. Best practices recommendations in the application of immunohistochemistry in the kidney tumors: Report from the International Society of Urologic Pathology[J]. Am J Surg Pathol, 2014, 38 (8): e35- e49.
doi: 10.1097/PAS.0000000000000258 |
20 |
Paner GP , Srigley JR , Radhakrishnan A , et al. Immunohistochemical analysis of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma of the kidney: Significant immunophenotypic overlap warrants diagnostic caution[J]. Am J Surg Pathol, 2006, 30 (1): 13- 19.
doi: 10.1097/01.pas.0000180443.94645.50 |
21 |
Uchida S , Suzuki K , Uno M , et al. Mucin-poor and aggressive mucinous tubular and spindle cell carcinoma of the kidney: Two case reports[J]. Mol Clin Oncol, 2017, 7 (5): 777- 782.
doi: 10.3892/mco.2017.1400 |
22 |
Kuroda N , Nakamura S , Miyazaki E , et al. Low-grade tubular-mucinous renal neoplasm with neuroendocrine differentiation: A histological, immunohistochemical and ultrastructural study[J]. Pathol Int, 2004, 54 (3): 201- 207.
doi: 10.1111/j.1440-1827.2004.01608.x |
23 |
Peckova K , Martinek P , Sperga M , et al. Mucinous spindle and tubular renal cell carcinoma: Analysis of chromosomal aberration pattern of low-grade, high grade, and an overlapping morphologic variant with papillary renal[J]. Ann Diagn Pathol, 2015, 19 (4): 226- 231.
doi: 10.1016/j.anndiagpath.2015.04.004 |
24 |
Kuroda N , Naroda T , Tamura M , et al. High-grade mucinous tubular and spindle cell carcinoma: Comparative genomic hybridization study[J]. Ann Diagn Pathol, 2011, 15 (6): 472- 475.
doi: 10.1016/j.anndiagpath.2010.08.003 |
25 |
Sadimin ET , Chen YB , Wang L , et al. Chromosomal abnormalities of high-grade mucinous tubular and spindle cell carcinoma of the kidney[J]. Histopathology, 2017, 71 (5): 719- 724.
doi: 10.1111/his.13298 |
26 |
Mehra R , Vats P , Cieslik M , et al. Bi-allelic alteration and dysregulation of the Hippo pathway in mucinous tubular and spindle cell carcinoma of the kidney[J]. Cancer Discov, 2016, 6 (11): 1258- 1266.
doi: 10.1158/2159-8290.CD-16-0267 |
27 |
Ren Q , Wang L , Al-Ahmadie HA , et al. Distinct genomic copy number alterations distinguish mucinous tubular and spindle cell carcinoma of the kidney from papillary renal cell carcinoma with overlapping histologic features[J]. Am J Surg Pathol, 2018, 42 (6): 767- 777.
doi: 10.1097/PAS.0000000000001038 |
28 |
邹子归, 王玉红, 周晋星, 等. 肾黏液样小管状和梭形细胞癌临床病理分析及全外显子组测序分析[J]. 中华病理学杂志, 2021, 50 (7): 762- 767.
doi: 10.3760/cma.j.cn112151-20200922-00731 |
29 |
Xu H , Li W , Zhu C , et al. Proteomic profiling identifies novel diagnostic biomarkers and molecular subtypes for mucinous tubular and spindle cell carcinoma of the kidney[J]. J Pathol, 2022, 257 (1): 53- 67.
doi: 10.1002/path.5869 |
30 |
Bharti JN , Choudhary GR , Madduri VKS , et al. Mucinous tubular and spindle cell carcinoma: A difficult diagnosis[J]. Urol Ann, 2021, 13 (2): 180- 182.
doi: 10.4103/UA.UA_44_20 |
31 |
Thway K , du Parcq J , Larkin JM , et al. Metastatic renal muci-nous tubular and spindle cell carcinoma. Atypical behavior of a rare, morphologically bland tumor[J]. Ann Diagn Pathol, 2012, 16 (5): 407- 410.
doi: 10.1016/j.anndiagpath.2011.04.001 |
32 |
Cossu-Rocca P , Eble JN , Delahunt B , et al. Renal mucinous tubular and spindle carcinoma lacks the gains of chromosomes 7 and 17 and losses of chromosome Y that are prevalent in papillary renal cell carcinoma[J]. Mod Pathol, 2006, 19 (4): 488- 493.
doi: 10.1038/modpathol.3800565 |
[1] | Yun-yi XU,Zheng-zheng SU,Lin-mao ZHENG,Meng-ni ZHANG,Jun-ya TAN,Ya-lan YANG,Meng-xin ZHANG,Miao XU,Ni CHEN,Xue-qin CHEN,Qiao ZHOU. Read-through circular RNA rt-circ-HS promotes hypoxia inducible factor 1α expression and renal carcinoma cell proliferation, migration and invasiveness [J]. Journal of Peking University (Health Sciences), 2023, 55(2): 217-227. |
[2] | Xiao-juan ZHU,Hong ZHANG,Shuang ZHANG,Dong LI,Xin LI,Ling XU,Ting LI. Clinicopathological features and prognosis of breast cancer with human epidermal growth factor receptor 2 low expression [J]. Journal of Peking University (Health Sciences), 2023, 55(2): 243-253. |
[3] | Yu-mei LAI,Zhong-wu LI,Huan LI,Yan WU,Yun-fei SHI,Li-xin ZHOU,Yu-tong LOU,Chuan-liang CUI. Clinicopathological features and prognosis of anorectal melanoma: A report of 68 cases [J]. Journal of Peking University (Health Sciences), 2023, 55(2): 262-269. |
[4] | Wei-hua HOU,Shu-jie SONG,Zhong-yue SHI,Mu-lan JIN. Clinicopathological features of Helicobacter pylori-negative early gastric cancer [J]. Journal of Peking University (Health Sciences), 2023, 55(2): 292-298. |
[5] | Fang CAO,Ming ZHONG,Cong-rong LIU. Uterine POLE mutant endometrioid carcinoma combined with human papilloma virus-associated cervical adenocarcinoma: A case report and literature review [J]. Journal of Peking University (Health Sciences), 2023, 55(2): 370-374. |
[6] | Xue-mei HA,Yong-zheng YAO,Li-hua SUN,Chun-yang XIN,Yan XIONG. Solid placental transmogrification of the lung: A case report and literature review [J]. Journal of Peking University (Health Sciences), 2023, 55(2): 357-361. |
[7] | Bo-han NING,Qing-xia ZHANG,Hui YANG,Ying DONG. Endometrioid adenocarcinoma with proliferated stromal cells, hyalinization and cord-like formations: A case report [J]. Journal of Peking University (Health Sciences), 2023, 55(2): 366-369. |
[8] | Qian SU,Xin PENG,Chuan-xiang ZHOU,Guang-yan YU. Clinicopathological characteristics and prognosis of non-Hodgkin lymphoma in oral and maxillofacial regions: An analysis of 369 cases [J]. Journal of Peking University (Health Sciences), 2023, 55(1): 13-21. |
[9] | Quan ZHANG,Hai-feng SONG,Bing-lei MA,Zhe-nan ZHANG,Chao-hui ZHOU,Ao-lin LI,Jun LIU,Lei LIANG,Shi-yu ZHU,Qian ZHANG. Pre-operative prognostic nutritional index as a predictive factor for prognosis in non-metastatic renal cell carcinoma treated with surgery [J]. Journal of Peking University (Health Sciences), 2023, 55(1): 149-155. |
[10] | Xiao-yan XING,Jun-xiao ZHANG,Feng-yun-zhi ZHU,Yi-fan WANG,Xin-yao ZHOU,Yu-hui LI. Clinical analysis of 5 cases of dermatomyositis complicated with macrophage activation syndrome [J]. Journal of Peking University (Health Sciences), 2022, 54(6): 1214-1218. |
[11] | Le-qing CAO,Jing-rui ZHOU,Yu-hong CHEN,Huan CHEN,Wei HAN,Yao CHEN,Yuan-yuan ZHANG,Chen-hua YAN,Yi-fei CHENG,Xiao-dong MO,Hai-xia FU,Ting-ting HAN,Meng LV,Jun KONG,Yu-qian SUN,Yu WANG,Lan-ping XU,Xiao-hui ZHANG,Xiao-jun HUANG. Relationship between treatment and prognosis in patients with late-onset severe pneumonia after allogeneic hematopoietic stem cell transplantation [J]. Journal of Peking University (Health Sciences), 2022, 54(5): 1013-1020. |
[12] | Tian-yu CAI,Zhen-peng ZHU,Chun-ru XU,Xing JI,Tong-de LV,Zhen-ke GUO,Jian LIN. Expression and significance of fibroblast growth factor receptor 2 in clear cell renal cell carcinoma [J]. Journal of Peking University (Health Sciences), 2022, 54(4): 628-635. |
[13] | Cai-peng QIN,Yu-xuan SONG,Meng-ting DING,Fei WANG,Jia-xing LIN,Wen-bo YANG,Yi-qing DU,Qing LI,Shi-jun LIU,Tao XU. Establishment of a mutation prediction model for evaluating the efficacy of immunotherapy in renal carcinoma [J]. Journal of Peking University (Health Sciences), 2022, 54(4): 663-668. |
[14] | Min QIU,Yan-yan LIAN,Min LU,Bin-shuai WANG,Xiao-jun TIAN,Jian LU,Cheng LIU,Shu-dong ZHANG,Min JIANG,Lu-lin MA. Treatment and prognosis of multiple primary malignant neoplasms complicated with renal cell carcinoma [J]. Journal of Peking University (Health Sciences), 2022, 54(4): 680-685. |
[15] | Er-shu BO,Peng HONG,Yu ZHANG,Shao-hui DENG,Li-yuan GE,Min LU,Nan LI,Lu-lin MA,Shu-dong ZHANG. Clinicopathological features and prognostic analysis of papillary renal cell carcinoma [J]. Journal of Peking University (Health Sciences), 2022, 54(4): 615-620. |